DMT rapidly induces a short-lasting altered state of consciousness marked by physical transcendence, vivid auditory distortions, and visual imagery. Using simultaneous fMRI and EKG data from 14 healthy volunteers before, during, and after intravenous DMT or placebo, a brain substate emerged immediately after DMT injection, characterized by deactivations in the hippocampus and medial parietal cortex and increased activity in the superior temporal lobe. Hippocampal and medial parietal deactivations correlated with altered sense of time, space, and self-referential processes, reflecting a deconstruction of ordinary consciousness. Superior temporal lobe activations correlated with audio/visual hallucinations and the experience of "entities.
Neurofeedback (NF) has been proposed as a tool to support meditation practice, but a systematic review mapping the field across clinical and non-clinical contexts reveals that most studies are proof-of-concept and vary widely in design, implementation, and outcome measures. While NF consistently modulates neural activity, evidence for corresponding improvements in behavior, phenomenology, or transferable meditative skills remains limited. The review concludes that additional research is essential to determine whether NF can help practitioners overcome common meditative barriers, such as anxiety and self-doubt, and accelerate meditative development from novice to advanced meditators.